Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest colitis Stories

2013-10-16 00:20:40

Phase II Trial to Focus on Moderate to Severe UC Patients with Eotaxin-1 Biomarker TARRYTOWN, N.Y. and HERZLIYA-PITUACH, Israel, Oct. 16, 2013 /PRNewswire/ -- Immune Pharmaceuticals Inc. (OTCQX and NASDAQ OMX Stockholm Exchange: IMNP) announced today that Tomer Adar, M.D. at the Digestive Diseases Institute, Shaare Zedek Medical Center, Hebrew University of Jerusalem, presented a poster on October 15, 2013 entitled Inhibition of Eotaxin-1 (CCL 11) Ameliorates DSS-Induced Colitis; A...

2013-10-14 16:24:13

ST. LOUIS, Oct. 14, 2013 /PRNewswire/ -- National food safety lawyer Ron Simon has filed two more lawsuits in St. Louis stemming from a multi-state E. coli O157:H7 outbreak linked to contaminated romaine lettuce sold at Schnucks salad bars during October 2011. The lawsuits were filed in St. Louis County, Missouri on behalf of Angela Crowell and Mark Bassemier against Schnucks Markets, Vaughan Foods, and others. Copies of the file-stamped lawsuits are available upon request. The...

2013-10-09 08:26:10

THE WOODLANDS, Texas, Oct. 9, 2013 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced top-line results from a pilot study exploring the use of telotristat etiprate in ulcerative colitis. Telotristat etiprate, a serotonin synthesis inhibitor, is currently in Phase 3 development for carcinoid syndrome, a condition caused by metastatic, functioning neuroendocrine tumors. Elevated serotonin is a hallmark of carcinoid syndrome, and two previous Phase 2...

2013-10-01 23:04:08

HB 1183, which passed the General Assembly and was signed into law by Governor Martin O’Malley on April 18, 2013 expands access to an “employee only” bathroom in retail establishments for Ostomy patients as well as individuals suffering from Crohn’s Disease, Ulcerative Colitis, and other medical conditions that require immediate access to a restroom, when no public restroom facilities are otherwise available. Rockville, MD (PRWEB) October 01, 2013 Metro Maryland Ostomy...

Mucus Protects Gut
2013-09-27 13:23:45

Michael Harper for redOrbit.com - Your Universe Online Researchers from the Icahn School of Medicine at Mount Sinai’s Immunology Institute say they’ve discovered an important role played by mucus in the gut. Though little was previously known about mucus, the Icahn doctors say the slimy, sticky stuff acts as an anti-inflammatory in the stomach and provides a protective self-regulating immune function. The research also showed that mucus acts as a protective barrier against bacteria...

2013-09-04 12:34:08

DEERFIELD, Ill. and OSAKA, Japan, Sept. 4, 2013 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., today announced that the United States (U.S.) Food and Drug Administration (FDA) has granted Priority Review status for the Biologics License Application (BLA) for its new investigational drug vedolizumab for the treatment of adults with moderately to severely active ulcerative colitis. A BLA was...

2013-08-22 12:52:15

Vedolizumab, a new intravenous antibody medication, has shown positive results for treating both Crohn's disease and ulcerative colitis, according to researchers at the University of California San Diego, School of Medicine. The findings, published in two papers, will appear in the August 22 issue of the New England Journal of Medicine (NEJM). William Sandborn, MD, principal investigator of the Crohn's disease study, said the results offer new hope to the more than one million Americans...

2013-08-15 23:19:01

iPhone APP and mobile friendly website. Bala Cynwyd, PA (PRWEB) August 15, 2013 The Crohn’s & Colitis Foundation of America is getting more mobile with a new interactive disease management tracker GI Buddy (available online and as an iPhone® app) and mobile friendly website. GI Buddy allows users to manage and track all aspects of their disease and construct a comprehensive view of disease impact including: symptoms, treatment, diet, and lifestyle. Crohn's disease and...

2013-08-01 23:18:42

Saturday, September 21st, 2013 @ SugarHouse Casino Philadelphia, PA (PRWEB) August 01, 2013 The Philadelphia/Delaware Valley Chapter of the Crohn’s Colitis Foundation of America (CCFA) proudly presents the 18th Annual Sippin’ by the River on Saturday, September 21st, rain or shine, from 1pm-5pm. After taking a short hiatus from the Philadelphia side of the Delaware waterfront, the Sippin’ by the River team is pleased to announce this year’s location and event sponsor: SugarHouse...

2013-07-31 23:32:47

Crohn’s Disease and Ulcerative Colitis More Common Amongst Ashkenazi Jews New York, New York (PRWEB) July 31, 2013 Individuals seeking to learn about Crohn’s disease and ulcerative colitis (collectively known as inflammatory bowel disease, or IBD) can self-educate at GeneSights, the free online education resource presented by the Program for Jewish Genetic Health of Yeshiva University/Albert Einstein College of Medicine. IBD affects more than 1.4 million Americans and its prevalence...


Latest colitis Reference Libraries

0_9f897835bb09adc2a84fda23893d87f8
2011-04-15 13:50:01

Clostridium difficile, also known as "CDF/cdf", or "C. diff", is a Gram-positive bacteria of the genus Clostridium that causes severe diarrhea and other intestinal disease when competing bacteria in the gut flora are wiped out by antibiotics. They are anaerobic, spore-forming rods and is the most serious cause of antibiotic-associated diarrhea and potentially to pseudomembranous colitis. C. difficile bacteria naturally resides in the gut of a small percentage of the adult population. Others...

More Articles (1 articles) »